Deletion of the lipid kinase PIKfyve in Kras-driven pancreatic genetically engineered mouse model

被引：0
|
作者：
Yee, Sarah N.
Jiang, Xia
Cheng, Caleb
Korkaya, Ahmet
Mannan, Rahul
Mehra, Rohit
Qiao, Yuanyuan
Chinnaiyan, Arul M.
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-4323
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4323
引用
收藏
页数：2
相关论文
共 50 条
  • [41] IKKβ Kinase Promotes Stemness, Migration, and Invasion in KRAS-Driven Lung Adenocarcinoma Cells
    Rodrigues, Felipe Silva
    Miranda, Vanessa Silva
    Carneiro-Lobo, Tatiana Correa
    Scalabrini, Luiza Coimbra
    Kruspig, Bjorn
    Levantini, Elena
    Murphy, Daniel J.
    Basseres, Daniela Sanchez
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (16) : 1 - 19
  • [42] Dimethylaminoparthenolide and gemcitabine: a survival study using a genetically engineered mouse model of pancreatic cancer
    Yip-Schneider, Michele T.
    Wu, Huangbing
    Stantz, Keith
    Agaram, Narasimhan
    Crooks, Peter A.
    Schmidt, C. Max
    BMC CANCER, 2013, 13
  • [43] Preclinical molecular targeting therapy of pancreatic cancer using a genetically engineered mouse model
    Miyabayashi, Koji
    Ijichi, Hideaki
    Mohri, Dal
    Tada, Motohisa
    Asaoka, Yoshinari
    Ikenoue, Tsuneo
    Omata, Masao
    Moses, Harold L.
    Koike, Kazuhiko
    CANCER RESEARCH, 2011, 71
  • [44] Anti-Tumour Efficacy of Capecitabine in a Genetically Engineered Mouse Model of Pancreatic Cancer
    Courtin, Aurelie
    Richards, Frances M.
    Bapiro, Tashinga E.
    Bramhall, Jo L.
    Neesse, Albrecht
    Cook, Natalie
    Krippendorff, Ben-Fillippo
    Tuveson, David A.
    Jodrell, Duncan I.
    PLOS ONE, 2013, 8 (06):
  • [45] A Dual-Color Genetically Engineered Mouse Model for Multispectral Imaging of the Pancreatic Microenvironment
    Snyder, Cynthia S.
    Harrington, Austin R.
    Kaushal, Sharmeela
    Mose, Evangeline
    Lowy, Andrew M.
    Hoffman, Robert M.
    Bouvet, Michael
    PANCREAS, 2013, 42 (06) : 952 - 958
  • [46] Characterization of a genetically engineered mouse model of hemophilia A with complete deletion of the F8 gene
    Chao, B. N.
    Baldwin, W. H.
    Healey, J. F.
    Parker, E. T.
    Shafer-Weaver, K.
    Cox, C.
    Jiang, P.
    Kanellopoulou, C.
    Lollar, P.
    Meeks, S. L.
    Lenardo, M. J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2016, 14 (02) : 346 - 355
  • [47] Dimethylaminoparthenolide and gemcitabine: a survival study using a genetically engineered mouse model of pancreatic cancer
    Michele T Yip-Schneider
    Huangbing Wu
    Keith Stantz
    Narasimhan Agaram
    Peter A Crooks
    C Max Schmidt
    BMC Cancer, 13
  • [48] Efficacy of Dimethylaminoparthenolide and Sulindac in Combination With Gemcitabine in a Genetically Engineered Mouse Model of Pancreatic Cancer
    Yip-Schneider, Michele T.
    Wu, Huangbing
    Hruban, Ralph H.
    Lowy, Andrew M.
    Crooks, Peter A.
    Schmidt, Christian Max
    PANCREAS, 2013, 42 (01) : 160 - 167
  • [49] Autophagy modulates lipid metabolism in Liver Kinase B1 (LKB1)-deficient Kras-driven lung tumorigenesis
    Bhatt, Vrushank Dharmesh
    Khayati, Khoosheh
    Hu, Zhixian
    Su, Xiaoyang
    Guo, Jessie Yanxiang
    FASEB JOURNAL, 2019, 33
  • [50] Dicer Is Required for Maintenance of Adult Pancreatic Acinar Cell Identity and Plays a Role in Kras-Driven Pancreatic Neoplasia
    Wang, Yue J.
    McAllister, Florencia
    Bailey, Jennifer M.
    Scott, Sherri-Gae
    Hendley, Audrey M.
    Leach, Steven D.
    Ghosh, Bidyut
    PLOS ONE, 2014, 9 (11):
12345